(R)-Oxiran-2-ylmethyl 3-nitrobenzenesulfonate, 95.0%, 5g

(2R)-1-(11bR)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,2,3,4-tetrahydro-2-methylquinoline, 97%, 100mg

Tris(4-(1H-imidazol-1-yl)phenyl)amine, 97%, 250mg

N-benzyl-6-methylbenzo[d]thiazol-2-amine, 95.0%, 500mg

C -(1,3-Dimethyl-1 H -pyrazol-4-yl)-methylamine, 95.0%, 5g

Ethyl 2-oxo-2,3-dihydrooxazole-5-carboxylate, 95.0%, 1g

Methyl 2-hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 10g

Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate, 95.0%, 25g

4-Nitrophenyl alpha-D-Galactopyranoside [Substrate for alpha-D-Galactosidase]>98.0%(HPLC)200mg

7-Chloro-6-nitroquinazolin-4(3H)-one, 95.0%, 25g

(S)-(-)-1-Phenylethylamine, 99.0%, 470g

(1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid, 95.0%, 5g

Chlorpheniramine Maleate>99.0%(HPLC)(T)25g